Farma&Cie SRL
Farma&Cie reported total assets of €2.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026).
By total assets for 2025, Farma&Cie ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Farma&Cie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +151 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farma&Cie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 11 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Farma&Cie's financial analysis
- Solvency33.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farma&Cie
Farma&Cie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0668.680.188
- VAT number
- BE0668680188
- Peppol
- Registered · 0208:0668680188 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jan 2017
- Registered office
- 2650 Edegem
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Farma&Cie (SRL) has been based in Edegem since 2017, active in: activities of holding companies. For 2025, it reports a net profit of 140,442 € and equity of 899,986 €; its revenue is not published. Its solvency stands at 33.4%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farma&Cie
Companies in the same business, of comparable size and area, outside its group.
- Krivis Activities of holding companies Wichelen · balance sheet €2.69m
- Addingmoore Activities of holding companies Dentergem · balance sheet €2.69m
- Vandenbussche Invest Activities of holding companies Roeselare · balance sheet €2.69m
- Ircom Activities of holding companies Lede · balance sheet €2.69m
- Applitec Activities of holding companies Herve · balance sheet €2.70m
- Foronex Groep Activities of holding companies Wielsbeke · balance sheet €2.70m
- ALS Group Activities of holding companies Anderlecht · balance sheet €2.70m
- Code 84 Activities of holding companies Ghent · balance sheet €2.69m
Frequently asked questions about Farma&Cie
What is the revenue of Farma&Cie?
Farma&Cie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farma&Cie?
In Belgium, the VAT number is the company number prefixed with BE: BE0668680188 for Farma&Cie, if the company is VAT-registered. Its company number (CBE) is 0668.680.188.
Where is the registered office of Farma&Cie?
According to the CBE register, the registered office of Farma&Cie is in 2650 Edegem.
What is the equity of Farma&Cie?
At the close of the 2025 financial year, the equity of Farma&Cie amounts to 899,986 €, a solvency of 33.4% of total assets.
Who manages Farma&Cie?
The register lists 1 active mandates at Farma&Cie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Farma&Cie within its sector?
By total assets for 2025, Farma&Cie ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Farma&Cie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →